SCHEMBL23920922

SCHEMBL23920922

CCOC(C)(C)CCNC(=O)CSc1nc2c(=O)[nH]c(N)nc2n1CCO

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PNP P00491 4/20 0.38
ALDH1A1 P00352 4/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ATM Q13315 1/20 0.33
TSHR P16473 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
MAPK1 P28482 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
MAPT P10636 1/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25928193 0.88 PNP (0.37) PNPALDH1A1KMT2AKDM4ETSHR
SCHEMBL23921227 0.86 ALDH1A1 (0.47) PNPALDH1A1KMT2AKDM4ETSHR
SCHEMBL23920989 0.84 ATM (0.46) PNPALDH1A1KDM4EATMTSHR
SCHEMBL21396481 0.80 MEN1 (0.44) PNPALDH1A1KMT2AKDM4EATM
SCHEMBL25928360 0.79 ALDH1A1 (0.35) ALDH1A1KMT2AKDM4EATMTSHR
SCHEMBL23921107 0.78 PNP (0.47) PNPALDH1A1TSHRMAPK1GAA
SCHEMBL21396435 0.78 PNP (0.42) PNPALDH1A1TSHRNPSR1CYP3A4
SCHEMBL21396394 0.76 PNP (0.51) PNPALDH1A1KDM4ETSHRHPGD
SCHEMBL23921094 0.76 PNP (0.48) PNPALDH1A1KMT2ATSHRHPGD
SCHEMBL21396401 0.76 PNP (0.42) PNPTSHRCYP3A4MAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2023-08-03 US disclosed
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PRKAG3 PNP 111/4885ALDH1A1 3952/4885KMT2A 2118/4885
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PDE7A PNP 106/4885ALDH1A1 3981/4885KMT2A 2369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.